Companies: 10,639     total market cap: โ‚ฌ115.859 T
๐Ÿ‡ฉ๐Ÿ‡ช Deutsch๐Ÿ‡ซ๐Ÿ‡ท Franรงais
$USD๐Ÿ‡บ๐Ÿ‡ธโ‚นINR๐Ÿ‡ฎ๐Ÿ‡ณยฃGBP๐Ÿ‡ฌ๐Ÿ‡ง$CAD๐Ÿ‡จ๐Ÿ‡ฆ$AUD๐Ÿ‡ฆ๐Ÿ‡บ$NZD๐Ÿ‡ณ๐Ÿ‡ฟ$HKD๐Ÿ‡ญ๐Ÿ‡ฐ$SGD๐Ÿ‡ธ๐Ÿ‡ฌ
Relmada Therapeutics
RLMD
#7851
Rank
โ‚ฌ0.27 B
Marketcap
๐Ÿ‡บ๐Ÿ‡ธ United States
Country
3,77ย โ‚ฌ
Share price
6.76%
Change (1 day)
745.73%
Change (1 year)
๐Ÿ’Š Pharmaceuticals๐Ÿงฌ Biotech
Categories

EPS for Relmada Therapeutics (RLMD)

EPS in 2025 (TTM): -1,99ย โ‚ฌ

According to Relmada Therapeutics's latest financial reports the company's current EPS (TTM) is -1,87ย โ‚ฌ. In 2024 the company made an earnings per share (EPS) of -2,26ย โ‚ฌ an increase over its 2023 EPS that were of -2,80ย โ‚ฌ.

EPS history for Relmada Therapeutics from 2012 to 2025

Annual EPS

Year EPS Change
2025 (TTM)-1,99ย โ‚ฌ-12.19%
2024-2,26ย โ‚ฌ-19.21%
2023-2,80ย โ‚ฌ-38.11%
2022-4,53ย โ‚ฌ-25.98%
2021-6,11ย โ‚ฌ87.93%
2020-3,25ย โ‚ฌ39.05%
2019-2,34ย โ‚ฌ-4.2%
2018-2,44ย โ‚ฌ37.5%
2017-1,78ย โ‚ฌ100%
2016-0,89ย โ‚ฌ-87.56%
2015-7,14ย โ‚ฌ
2013-0,02697ย โ‚ฌ273.48%
2012-0,007221ย โ‚ฌ

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Taro Pharmaceutical
TARO
1,04ย โ‚ฌ-155.71%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
Cytokinetics
CYTK
-5,37ย โ‚ฌ 187.21%๐Ÿ‡บ๐Ÿ‡ธ USA

What is the market capitalization of a company?

The market capitalization sometimes referred as Marketcap, is the value of a publicly listed company.
In most cases it can be easily calculated by multiplying the share price with the amount of outstanding shares.

DISCLAIMER

CompaniesMarketCap is not associated in any way with CoinMarketCap.com
Stock prices are delayed, the delay can range from a few minutes to several hours.
Company logos are from the CompaniesLogo.com logo database and belong to their respective copyright holders. Companies Marketcap displays them for editorial purposes only.

Contact

For inquiries or if you want to report a problem write to hello@8marketcap.com

Links

- Privacy policy

- Terms and conditions

© 2025 CompaniesMarketcap.com